APA (7th ed.) Citation

DQ, H., & R, L. (2023). Editorial: Will MRI-PDFF become the new standard for steatosis assessment in NAFLD? Authors' reply. Alimentary pharmacology & therapeutics, 58(3), 366. https://doi.org/10.1111/apt.17619

Chicago Style (17th ed.) Citation

DQ, Huang, and Loomba R. "Editorial: Will MRI-PDFF Become the New Standard for Steatosis Assessment in NAFLD? Authors' Reply." Alimentary Pharmacology & Therapeutics 58, no. 3 (2023): 366. https://doi.org/10.1111/apt.17619.

MLA (9th ed.) Citation

DQ, Huang, and Loomba R. "Editorial: Will MRI-PDFF Become the New Standard for Steatosis Assessment in NAFLD? Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 58, no. 3, 2023, p. 366, https://doi.org/10.1111/apt.17619.